Estrategia farmacoinvasiva en Latinoamérica ¿por qué no la vemos como nuestra opción?

Alexandra Arias-Mendoza

doi:10.47487/apcyccv.v5i1.355

Authors

Alexandra Arias-Mendoza Instituto Nacional de Cardiología Ignacio Chávez. Ciudad de México, México. https://orcid.org/0000-0002-5942-4102

DOI:

https://doi.org/10.47487/apcyccv.v5i1.355

Keywords:

ST Elevation Myocardial Infarction, Fibrinolysis, Angioplasty, Balloon, Coronary

Downloads

Download data is not yet available.

References

Custodio-Sánchez P, Miranda-Noé D, López-Rojas LM, Paredes Paucar CP, Yábar-Galindo EG, Rojas De La Cuba P, et al. Propuesta de manejo inicial del infarto de miocardio con elevación del segmento ST no complicado en centros sin capacidad de intervención coronaria percutánea en el Perú. Arch Perú Cardiol Cir Cardiovasc. 2023;4(4):164-83. doi: 10.47487/apcyccv.v4i4.335.

Araiza-Garaygordobil D, Gopar-Nieto R, Cabello-López A, Martínez-Amezcua P, Eid-Lidt G, Baeza-Herrera LA, et al. Pharmacoinvasive Strategy vs Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Study in Mexico City. CJC Open. 2020;3(4):409-418. doi: 10.1016/j.cjco.2020.11.012.

Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.

Francesco Borgia, Shaun G. Goodman, Sigrun Halvorsen, Warren J. Cantor, Federico Piscione, Michel R. Le May, et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J. 2010;31(17):2156-69. doi: 10.1093/eurheartj/ehq204.

Bhan V, Cantor WJ, Yan RT, Mehta SR, Morrison LJ, Heffernan M, et al. Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). Am Heart J. 2012;164(3):343-50. doi: 10.1016/j.ahj.2012.05.022.

Arias-Mendoza A, Ortega-Hernández JA, Araiza-Garaygordobil D, González-Pacheco H, Martínez-García M, Hernández-Lemus E, et al. Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits. Ther Clin Risk Manag. 2023;19:903-911. doi: 10.2147/TCRM.S432683.

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.